(Q44318845)

English

Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

steatohepatitis

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

author name string

Perry Hookman

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jamie S Barkin

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

495-499

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Effect of metformin on food intake in obese subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Leptin regulation of the immune response and the immunodeficiency of malnutrition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Transdifferentiation of rat hepatic stellate cells results in leptin expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07276.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2003.07276.X

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44318845&oldid=2109408023"